Department of Biomedicine

You are here: » Demi van der Horst » Research outputs

Demi van der Horst

1 - 4 out of 4Page size: 100
RSS feed of this list
  1. 2022
  2. Published
    Regulation of innate immunity by Nrf2. / van der Horst, D.; Carter-Timofte, M. E.; van Grevenynghe, J. et al.
    In: Current Opinion in Immunology, Vol. 78, 102247, 10.2022.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

  3. 2021
  4. Published
    Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern. / Carter-Timofte, Madalina Elena; Arulanandam, Rozanne; Kurmasheva, Naziia et al.
    In: ACS Infectious Diseases, Vol. 7, No. 11, 10.2021, p. 3034-3051.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  5. 2020
  6. Published
    Defects in LC3B2 and ATG4A underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humans. / Hait, Alon Schneider; Olagnier, David; Sancho-Shimizu, Vanessa et al.
    In: Science Immunology, Vol. 5, No. 54, eabc2691, 12.2020.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

  7. Published
    SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. / Olagnier, David; Farahani, Ensieh; Thyrsted, Jacob et al.
    In: Nature Communications, Vol. 11, No. 1, 4938, 10.2020.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review